was first reported in Wuhan (China) and has rapidly disseminated around the globe [1]. Only one year after the pandemic outbreak, scientists have developed efficient vaccines andpromisingtherapeutic interventions, such as monoclonal antibodies (mAbs). However,SARS-CoV-2 variantsaccumulating mutations...
Explore BPS Bioscience’s tools for studying SARS-CoV-2 variants. Advance research on viral mutations and their effects on disease and treatment.
新冠突变株简介 世界卫生组织从2020年1月起一直在监测和评估全球新冠病毒的变异,建立了区分新出现的SARS-CoV-2变体的分类系统:Variants of Concern (VOCs)和Variants of interest(VOIs)。 如Alpha (B.1.1.7)、Beta (B.1.351)、Gamma (P.1)和Delta (B.1.617.2),均与传播性和毒力增强有关,被列为"令人担忧...
文献阅读——SARS-CoV-2 Beta and Delta variants trigger Fc effector function with increased ... goblin7 20508 目录 收起 1. Author 2. Background 2.1 Fc段效应功能 2.2 腺病毒疫苗 2.3 Ad26.COV2.S疫苗 3. Methods 4. Results 5. Discussion 1. Author Penny L. Moore Penny Moore是威特沃特斯...
SARS-CoV-2 Variants of Concern in the United States Rochelle P. Walensky, MD, MPH; Henry T. Walke, MD, MPH; Anthony S. Fauci, MD JAMA Research Letter Emergence of a Novel SARS-CoV-2 Variant in Southern California Wenjuan Zhang, PhD; Brian D. Davis, BSc; Stephanie S. Chen, BSc; ...
SARS-CoV-2 variants Detect the presence and manage the impact of SARS-CoV-2 variants Widespread, standardised efforts to monitor and sequence SARS-CoV-2 samples will enable fast, efficient identification and management of viral mutations.
1. WHO.WHO announces simple, easy-to-say labels for SARS-CoV-2 Variants ofInterest and Concern 2021 [cited 2021 JUN 22]. Available from:https://www.who.int/news/item/31-05-2021-who-announces-simple-easy-to-say-labels-for-sars-cov-2-variants-of-interest-and-concern. ...
腺病毒(Adenovirus ,Ad )载体过去曾被用于针对其他病毒的疫苗,特别是HIV 和埃博拉病毒,但从未被大规模地生产、分发或用于人类。有研究对几种不同血清型的编码SARS-CoV-2 S 蛋白的Ad 进行测试,发现其对COVID-19 有效。 Ad 是无包膜的双链DNA 病毒,其二十面体衣壳直径在80 -100 nm之间,可感染多种细胞,包括...
A nanomaterial targeting the spike protein captures SARS-CoV-2 variants and promotes viral elimination 期刊:Nature Nanotechnology 影响因子:40.523 PMID:35995853 DOI:10.1038/s41565-022-01177-2 通讯作者: 郑永唐、李红昌、陈春英、王黎明、李洋 作者单位: ...
Since the outbreak of the coronavirus disease 2019 (COVID-19) pandemic, there have been a few variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), one of which is the Omicron variant (B.1.1.529). The Omicron variant is the most m